ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $404,123 | +194.6% | 36,147 | +73.9% | 0.00% | – |
| Q1 2024 | $137,174 | +63.5% | 20,784 | -8.6% | 0.00% | – |
| Q2 2023 | $83,892 | -11.2% | 22,735 | -20.4% | 0.00% | – |
| Q1 2023 | $94,517 | -13.2% | 28,555 | +1.8% | 0.00% | – |
| Q4 2022 | $108,884 | +105.4% | 28,063 | +28.9% | 0.00% | – |
| Q3 2022 | $53,000 | – | 21,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |